Screening technology for optimal medical materials (MedScreen)

In this SNN-EFRO-project BiomACS' screening technology will make the transition from in vitro screening to in vivo preclinical validated new cardiovascular stents. BiomACS is teaming-up with the UMCG-Surgery, Biomedical Engineering, and Bentley to develop a novel endovascular stent graft that minimizes secondary complications such as leakage and displacement.